EyeGene, Inc.

EyeGene, Inc. financial statements

EyeGene, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueKRW 3.57BEODHD
Net income−KRW 15.71BEODHD
Cash and equivalentsKRW 10.19BEODHD

EyeGene, Inc. financials on 6ix · EyeGene, Inc. on 6ix